Kymera Therapeutics (KYMR) Interest Coverage Ratio (2019 - 2025)
Historic Interest Coverage Ratio for Kymera Therapeutics (KYMR) over the last 7 years, with Q3 2025 value amounting to 944.09.
- Kymera Therapeutics' Interest Coverage Ratio rose 2146.09% to 944.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 985.93, marking a year-over-year decrease of 1918.33%. This contributed to the annual value of 1050.74 for FY2024, which is 2441.59% down from last year.
- According to the latest figures from Q3 2025, Kymera Therapeutics' Interest Coverage Ratio is 944.09, which was up 2146.09% from 782.94 recorded in Q2 2025.
- Kymera Therapeutics' 5-year Interest Coverage Ratio high stood at 371.38 for Q4 2023, and its period low was 1402.66 during Q3 2023.
- Over the past 5 years, Kymera Therapeutics' median Interest Coverage Ratio value was 883.21 (recorded in 2021), while the average stood at 884.82.
- Per our database at Business Quant, Kymera Therapeutics' Interest Coverage Ratio soared by 4327.8% in 2023 and then plummeted by 26854.75% in 2024.
- Over the past 5 years, Kymera Therapeutics' Interest Coverage Ratio (Quarter) stood at 666.55 in 2021, then rose by 1.77% to 654.75 in 2022, then surged by 43.28% to 371.38 in 2023, then tumbled by 268.55% to 1368.73 in 2024, then skyrocketed by 31.02% to 944.09 in 2025.
- Its Interest Coverage Ratio was 944.09 in Q3 2025, compared to 782.94 in Q2 2025 and 1033.69 in Q1 2025.